These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 17076629
1. Pharmacokinetic analysis of platelet-activating factor in the tears of guinea pigs with allergic conjunctivitis. Okumura N, Fukushima A, Igarashi A, Sumi T, Yamagishi T, Ueno H. J Ocul Pharmacol Ther; 2006 Oct; 22(5):347-52. PubMed ID: 17076629 [Abstract] [Full Text] [Related]
2. Platelet-activating factor in human normal tears. Okumura N, Kojima K, Hashida M, Koura Y, Fukushima A, Ueno H. Curr Eye Res; 2005 Oct; 30(10):891-6. PubMed ID: 16251126 [Abstract] [Full Text] [Related]
3. Platelet activating factor degradation in tear fluid from guinea pigs with allergic conjunctivitis. Kato M, Mano H, Ota A, Konomi K, Nakata K. J Ocul Pharmacol Ther; 2001 Feb; 17(1):83-91. PubMed ID: 11327052 [Abstract] [Full Text] [Related]
4. Characterization of receptors for platelet-activating factor in guinea pig lung membranes. Gomez J, Bloom JW, Yamamura HI, Halonen M. Am J Respir Cell Mol Biol; 1990 Sep; 3(3):259-64. PubMed ID: 2167700 [Abstract] [Full Text] [Related]
5. Decrease of ciliary beat frequency by platelet activating factor: protective effect of ketotifen. Kahhak L, Roche A, Dubray C, Arnoux C, Benveniste J. Inflamm Res; 1996 May; 45(5):234-8. PubMed ID: 8737746 [Abstract] [Full Text] [Related]
6. Apafant, a potent platelet-activating factor antagonist, blocks eosinophil activation and is effective in the chronic phase of experimental allergic conjunctivitis in guinea pigs. Kato M, Imoto K, Miyake H, Oda T, Miyaji S, Nakamura M. J Pharmacol Sci; 2004 Aug; 95(4):435-42. PubMed ID: 15286429 [Abstract] [Full Text] [Related]
7. Renal allograft platelet activating factor synthesis during acute cellular rejection. Mangino MJ, Anderson CB, Murphy MK, Turk J. J Lipid Mediat; 1991 Aug; 4(1):69-81. PubMed ID: 1893087 [Abstract] [Full Text] [Related]
8. [Bioassay of Lyso-PAF platelet activating factor and it's role in bronchial asthma]. Fu J, Yu HP, Li PS. Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(1):30-2, 63. PubMed ID: 8403058 [Abstract] [Full Text] [Related]
9. The anaphylactic release of platelet-activating factor from perfused guinea-pig lungs. Fitzgerald MF, Moncada S, Parente L. Br J Pharmacol; 1986 May; 88(1):149-53. PubMed ID: 3708213 [Abstract] [Full Text] [Related]
10. Quantification of distinct molecular species of platelet activating factor in ulcerative colitis. Thyssen E, Turk J, Bohrer A, Stenson WF. Lipids; 1996 Mar; 31 Suppl():S255-9. PubMed ID: 8729129 [Abstract] [Full Text] [Related]
11. The role of platelet activating factor and the efficacy of apafant ophthalmic solution in experimental allergic conjunctivitis. Kato M, Kurose T, Oda T, Miyaji S. J Ocul Pharmacol Ther; 2003 Aug; 19(4):315-24. PubMed ID: 12964956 [Abstract] [Full Text] [Related]
13. A competitive receptor binding assay for platelet-activating factor (PAF): quantification of PAF in rat brain. Tiberghien C, Laurent L, Junier MP, Dray F. J Lipid Mediat; 1991 Mar; 3(3):249-66. PubMed ID: 1773028 [Abstract] [Full Text] [Related]
14. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models. Kida T, Fujii A, Sakai O, Iemura M, Atsumi I, Wada T, Sakaki H. Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793 [Abstract] [Full Text] [Related]
15. Species-specific variations in the molecular heterogeneity of the platelet-activating factor. Ramesha CS, Pickett WC. J Immunol; 1987 Mar 01; 138(5):1559-63. PubMed ID: 3100641 [Abstract] [Full Text] [Related]
16. Translocation of exogenous platelet-activating factor and its lyso-compound through plasma membranes is a rate-limiting step for their metabolic conversions into alkylacylglycerophosphocholines in rabbit platelets and guinea-pig leukocytes. Tokumura A, Tsutsumi T, Yoshida J, Tsukatani H. Biochim Biophys Acta; 1990 May 01; 1044(1):91-100. PubMed ID: 2340312 [Abstract] [Full Text] [Related]
17. [Detection of platelet-activating factor in nasal lavage fluid from patients with pollinosis and experimental animals with nasal allergy]. Shirasaki H, Asakura K. Nihon Jibiinkoka Gakkai Kaiho; 1990 Mar 01; 93(3):420-7. PubMed ID: 2352050 [Abstract] [Full Text] [Related]
18. Metabolism of platelet-activating factor in neutrophils isolated from Pichinde virus-infected guinea pigs. Qian C, Liu CT, Peters CJ. J Leukoc Biol; 1992 Mar 01; 51(3):210-3. PubMed ID: 1541904 [Abstract] [Full Text] [Related]
19. Platelet-activating factor in the inflammatory exudate in the anaphylactic phase of allergic inflammation in rats. Watanabe M, Ohuchi K, Sugidachi A, Hirasawa N, Hayashi Y, Tsurufuji S. Int Arch Allergy Appl Immunol; 1987 Mar 01; 84(4):396-403. PubMed ID: 3119503 [Abstract] [Full Text] [Related]
20. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation. Ring PC, Seldon PM, Barnes PJ, Giembycz MA. Mol Pharmacol; 1993 Feb 01; 43(2):302-12. PubMed ID: 8381515 [Abstract] [Full Text] [Related] Page: [Next] [New Search]